Filing Details
- Accession Number:
- 0001562180-19-005413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-08 17:01:40
- Reporting Period:
- 2019-11-06
- Accepted Time:
- 2019-11-08 17:01:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1680329 | Emma Reeve | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-06 | 56,542 | $6.61 | 56,542 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 9,084 | $7.60 | 65,626 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-06 | 2,574 | $16.31 | 63,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 4,158 | $17.59 | 58,894 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 24,264 | $18.40 | 34,630 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 6,188 | $19.20 | 28,442 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 11,976 | $20.01 | 16,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 15,740 | $29.75 | 726 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 726 | $30.84 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-06 | 56,542 | $0.00 | 56,542 | $6.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-06 | 9,084 | $0.00 | 9,084 | $7.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 87,793 | 2027-12-11 | No | 4 | M | Direct | |
| 28,612 | 2028-03-05 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $16.00 to $16.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $17.00 to $17.995. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $18.00 to $18.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $19.00 to $19.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $20.00 to $20.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $29.50 to $30.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on December 12, 2017. The shares underlying the option are scheduled to vest as to 25% of the shares underlying the option on October 16, 2018, with the remainder vesting in equal quarterly installments through October 16, 2021.
- This option was granted on March 6, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through March 6, 2022.
Billionaire Hedge Funds
